Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Publication year range
1.
J Food Biochem ; 43(7): e12871, 2019 07.
Article in English | MEDLINE | ID: mdl-31353726

ABSTRACT

Garlic has attracted considerable attention because of its bactericidal and anticancer effects. However, the greening of garlic purees greatly affects the product quality. This study investigated the influence of light colors and power on the greening of garlic, and determined the key substances of garlic puree greening, including γ-glutamyl transpeptidase (γ-GT), thiosulfinate, and alliinase. Results showed that purple light source greatly affects greening power, γ-GT, and thiosulfinate. Illumination using a 3-W power lamp could reduce the production of thiosulfinate and alliinase and inhibit the green transformation reaction. Illumination using a 5-W power lamp greatly affected the thiosulfinate content and greening power, whereas that using a 7-W power lamp greatly influenced the γ-GT activity, porphobilinogen content, and alliinase content. Results showed that the green color of garlic puree is greatly affected by the illumination color and intensity, which provides theoretical support for the anti-greening of light garlic puree. PRACTICAL APPLICATION: Because garlic puree easily turns green during processing, which affects the product quality and economic value, this study uses controllable light source radiation to influence the greening of garlic puree, hoping to delay or even solve this problem and provide a new simple method to prevent garlic puree from turning greening.


Subject(s)
Carbon-Sulfur Lyases/metabolism , Garlic/enzymology , Garlic/radiation effects , Plant Proteins/metabolism , gamma-Glutamyltransferase/metabolism , Color , Garlic/chemistry , Garlic/growth & development , Light , Pigments, Biological/analysis , Pigments, Biological/metabolism , Porphobilinogen/analysis , Porphobilinogen/metabolism
2.
J Clin Invest ; 121(12): 4861-9, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22105168

ABSTRACT

Oxidative modification of LDL is an early pathological event in the development of atherosclerosis. Oxidation events such as malondialdehyde (MDA) formation may produce specific, immunogenic epitopes. Indeed, antibodies to MDA-derived epitopes are widely used in atherosclerosis research and have been demonstrated to enable cardiovascular imaging. In this study, we engineered a transgenic zebrafish with temperature-inducible expression of an EGFP-labeled single-chain human monoclonal antibody, IK17, which binds to MDA-LDL, and used optically transparent zebrafish larvae for imaging studies. Feeding a high-cholesterol diet (HCD) supplemented with a red fluorescent lipid marker to the transgenic zebrafish resulted in vascular lipid accumulation, quantified in live animals using confocal microscopy. After heat shock-induced expression of IK17-EGFP, we measured the time course of vascular accumulation of IK17-specific MDA epitopes. Treatment with either an antioxidant or a regression diet resulted in reduced IK17 binding to vascular lesions. Interestingly, homogenates of IK17-EGFP-expressing larvae bound to MDA-LDL and inhibited MDA-LDL binding to macrophages. Moreover, sustained expression of IK17-EGFP effectively prevented HCD-induced lipid accumulation in the vascular wall, suggesting that the antibody itself may have therapeutic effects. Thus, we conclude that HCD-fed zebrafish larvae with conditional expression of EGFP-labeled oxidation-specific antibodies afford an efficient method of testing dietary and/or other therapeutic antioxidant strategies that may ultimately be applied to humans.


Subject(s)
Blood Vessels/metabolism , Cholesterol, Dietary/pharmacokinetics , Disease Models, Animal , Hypercholesterolemia/metabolism , Lipoproteins, LDL/metabolism , Malondialdehyde/analogs & derivatives , Microscopy, Confocal/methods , Microscopy, Fluorescence/methods , Zebrafish Proteins/metabolism , Zebrafish/metabolism , Animals , Animals, Genetically Modified , Antibodies, Monoclonal/genetics , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/therapeutic use , Anticholesteremic Agents/therapeutic use , Drug Evaluation, Preclinical , Epitopes/immunology , Genes, Reporter , Green Fluorescent Proteins/analysis , Green Fluorescent Proteins/genetics , Humans , Hydrazines/analysis , Hypercholesterolemia/drug therapy , Hypercholesterolemia/therapy , Immunoglobulin Fab Fragments/genetics , Lipoproteins, LDL/immunology , Macrophages/metabolism , Macrophages/ultrastructure , Malondialdehyde/immunology , Malondialdehyde/metabolism , Oxidation-Reduction , Porphobilinogen/analogs & derivatives , Porphobilinogen/analysis , Probucol/therapeutic use , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/therapeutic use , Single-Chain Antibodies/genetics , Single-Chain Antibodies/immunology , Single-Chain Antibodies/therapeutic use , Temperature , Veins/metabolism , Zebrafish/genetics , Zebrafish/growth & development , Zebrafish Proteins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL